{
  "$schema": "folio-library-document/v1",
  "id": "10665-351406",
  "title": "The case for investing in public health: the strengthening public health services and capacity. A key pillar of the European regional health policy framework Health 2020",
  "variant": "pdf",
  "pages": 40,
  "tocSource": "outline",
  "tocMethod": null,
  "toc": [
    {
      "level": 1,
      "title": "ABSTRACT",
      "number": null,
      "page": 4,
      "pageLabel": "ii",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-000-abstract"
    },
    {
      "level": 1,
      "title": "Keywords",
      "number": null,
      "page": 4,
      "pageLabel": "ii",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-001-keywords"
    },
    {
      "level": 1,
      "title": "CONTENTS",
      "number": null,
      "page": 4,
      "pageLabel": "ii",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-002-contents"
    },
    {
      "level": 1,
      "title": "Acknowledgements",
      "number": null,
      "page": 6,
      "pageLabel": "iv",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-003-acknowledgements"
    },
    {
      "level": 1,
      "title": "About this report",
      "number": null,
      "page": 7,
      "pageLabel": "1",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-004-about-this-report"
    },
    {
      "level": 1,
      "title": "Key messages",
      "number": null,
      "page": 7,
      "pageLabel": "1",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": null
    },
    {
      "level": 1,
      "title": "Overview",
      "number": null,
      "page": 9,
      "pageLabel": "3",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-005-overview"
    },
    {
      "level": 1,
      "title": "Background",
      "number": null,
      "page": 11,
      "pageLabel": "5",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-006-background"
    },
    {
      "level": 1,
      "title": "The economic case for prevention",
      "number": null,
      "page": 13,
      "pageLabel": "7",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-007-the-economic-case-for-prevention"
    },
    {
      "level": 1,
      "title": "The benefits of action",
      "number": null,
      "page": 17,
      "pageLabel": "11",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-008-the-benefits-of-action"
    },
    {
      "level": 1,
      "title": "Conclusions",
      "number": null,
      "page": 29,
      "pageLabel": "23",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-009-conclusions"
    }
  ],
  "sections": [
    {
      "id": "sec-front-matter",
      "number": null,
      "title": "Front matter",
      "level": 1,
      "pageStart": 1,
      "pageEnd": 4,
      "labelStart": "1",
      "labelEnd": "ii",
      "words": 55,
      "summary": {
        "text": "The cover and title pages of a WHO Europe public health summary report making the case for investing in public health, under essential public health operation 8 on sustainable structures and financing.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "epho",
          "heading": false
        },
        {
          "term": "public health",
          "heading": false
        },
        {
          "term": "health summary",
          "heading": false
        }
      ],
      "extract": "A public health summary report for EPHO 8 Assuring sustainable organizational structures and financing THE CASE FOR INVESTING IN PUBLIC HEALTH A public health summary report for EPHO 8 The strengthening public health services and capacity A key pillar of the European regional health policy framework Health 2020 THE CASE FOR INVESTING IN PUBLIC HEALTH",
      "extractCut": false,
      "blocks": [
        "library/10665-351406/blocks/prose-sec-front-matter",
        "library/10665-351406/blocks/figure-img-p001-1",
        "library/10665-351406/blocks/figure-img-p001-2",
        "library/10665-351406/blocks/figure-img-p001-3"
      ]
    },
    {
      "id": "sec-000-abstract",
      "number": null,
      "title": "ABSTRACT",
      "level": 1,
      "pageStart": 4,
      "pageEnd": 4,
      "labelStart": "ii",
      "labelEnd": "ii",
      "words": 172,
      "summary": {
        "text": "The report's abstract argues that, amid economic crisis and rising health costs, prevention can be cost-effective and give short- and long-term returns on investment. It highlights quick returns from interventions on physical activity, healthy employment, housing, mental health, road traffic injuries and violence, and notes population-level approaches cost much less than individual ones.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "returns",
          "heading": false
        },
        {
          "term": "health sector",
          "heading": false
        },
        {
          "term": "cost-effective",
          "heading": false
        },
        {
          "term": "public health",
          "heading": false
        },
        {
          "term": "investment",
          "heading": false
        },
        {
          "term": "interventions",
          "heading": false
        }
      ],
      "extract": "The economic crisis has led to increased demand and reduced resources for health sectors. The trend for increasing healthcare costs to individuals, the health sector and wider society is significant. Public health can be part of the solution to this challenge. The evidence shows that prevention can be cost-effective, provide value for money and give returns on investment in both the short and longer terms. This",
      "extractCut": true
    },
    {
      "id": "sec-001-keywords",
      "number": null,
      "title": "Keywords",
      "level": 1,
      "pageStart": 4,
      "pageEnd": 5,
      "labelStart": "ii",
      "labelEnd": "iii",
      "words": 79,
      "summary": {
        "text": "Lists the report's keywords and gives the document number, 2014 WHO copyright with restricted-use notice, photo credits and design credits.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "health care",
          "heading": false
        },
        {
          "term": "istock",
          "heading": false
        },
        {
          "term": "phoenix",
          "heading": false
        }
      ],
      "extract": "DELIVERY OF HEALTH CARE HEALTH CARE COSTS HEALTH CARE ECONOMICS AND ORGANIZATIONS HEALTH POLICY PREVENTION PUBLIC HEALTH Document number: WHO/EURO:2014-2581-42337-58615 © World Health Organization 2014 All rights reserved. This information material is intended for a limited audience only. It may not be reviewed, abstracted, quoted, reproduced, transmitted, distributed, translated or adapted, in part or in whole,in",
      "extractCut": true
    },
    {
      "id": "sec-002-contents",
      "number": null,
      "title": "CONTENTS",
      "level": 1,
      "pageStart": 5,
      "pageEnd": 6,
      "labelStart": "iii",
      "labelEnd": "iv",
      "words": 59,
      "summary": {
        "text": "The table of contents of the report on investing in public health.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "inequalities",
          "heading": false
        },
        {
          "term": "preparedness",
          "heading": false
        },
        {
          "term": "conclusions",
          "heading": false
        }
      ],
      "extract": "Acknowledgements.............................................................................................................................................................. iv About this report.................................................................................................................................................................... 1",
      "extractCut": true
    },
    {
      "id": "sec-003-acknowledgements",
      "number": null,
      "title": "Acknowledgements",
      "level": 1,
      "pageStart": 6,
      "pageEnd": 7,
      "labelStart": "iv",
      "labelEnd": "1",
      "words": 277,
      "summary": {
        "text": "Names the authors of the public health summary report from the WHO Regional Office for Europe, the London School of Economics and the University of Athens, and thanks WHO colleagues and other contributors. It notes the work builds on earlier economic reviews and contributions to a 2013 Oslo conference on health systems and the economic crisis.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "regional office",
          "heading": false
        },
        {
          "term": "london school",
          "heading": false
        },
        {
          "term": "country office",
          "heading": false
        },
        {
          "term": "public health",
          "heading": false
        },
        {
          "term": "health systems",
          "heading": false
        },
        {
          "term": "division",
          "heading": false
        },
        {
          "term": "health services",
          "heading": false
        },
        {
          "term": "co-operation",
          "heading": false
        }
      ],
      "extract": "This public health summary report was prepared by Joanna Nurse, Stephen Dorey, Lin Yao, Louise Sigfrid and Platonas Yfantopolous, formerly from Public Health Services, Division of Health Systems and Public Health, WHO Regional Office for Europe; David McDaid, London School of Economics; John Yfantopolous, University of Athens; and Jose Martin Moreno, formerly of the WHO Regional Office for Europe. The authors wish",
      "extractCut": true
    },
    {
      "id": "sec-004-about-this-report",
      "number": null,
      "title": "About this report",
      "level": 1,
      "pageStart": 7,
      "pageEnd": 9,
      "labelStart": "1",
      "labelEnd": "3",
      "words": 1037,
      "summary": {
        "text": "Describes the report's audience, defines public health and its three domains, and links the report to Health 2020 and essential public health operation 8 on organisational structures and financing. It lists objectives such as setting out the cost of inaction and summarising evidence on cost-effective prevention and returns on investment. Key messages state that current costs of ill health are unsustainable and that many kinds of prevention are cost-effective in the short and longer term.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "cost-effective health",
          "heading": false
        },
        {
          "term": "road traffic",
          "heading": false
        },
        {
          "term": "returns",
          "heading": false
        },
        {
          "term": "billion",
          "heading": false
        },
        {
          "term": "economic crisis",
          "heading": false
        },
        {
          "term": "environmental benefits",
          "heading": false
        },
        {
          "term": "public health",
          "heading": false
        },
        {
          "term": "mental health",
          "heading": false
        }
      ],
      "extract": "planners and managers, as well as wider decision- makers and policy-makers both in national and local governmental and professional roles in health and social care settings and in broader roles influencing health and well-being. Scope Public health is defined as “the art and science of preventing disease, prolonging life and promoting health through the organized efforts of society” (Acheson, 1988). It consists of",
      "extractCut": true
    },
    {
      "id": "sec-005-overview",
      "number": null,
      "title": "Overview",
      "level": 1,
      "pageStart": 9,
      "pageEnd": 11,
      "labelStart": "3",
      "labelEnd": "5",
      "words": 1048,
      "summary": {
        "text": "Gives an overview of cost-effective public health interventions in a figure and a table that separates quick wins within five years from longer-term gains. Examples span environmental and social determinants, resilience and mental health, behaviours such as tobacco and alcohol control, and vaccination and screening. A box stresses the importance of nutrition in the first 1000 days, and the section notes how the economic crisis has weakened public health responses while demand for care grows.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "longer-term gains",
          "heading": false
        },
        {
          "term": "health budgets",
          "heading": false
        },
        {
          "term": "violence prevention",
          "heading": false
        },
        {
          "term": "upward pressure",
          "heading": false
        },
        {
          "term": "cost-effective",
          "heading": false
        },
        {
          "term": "maternal nutrition",
          "heading": false
        },
        {
          "term": "quick wins",
          "heading": false
        },
        {
          "term": "tobacco control",
          "heading": false
        }
      ],
      "extract": "Fig. 1. Cost-effective public health interventions Source: WHO (2013a). green Space employment housing transport environment physical activity Mental health violence prevention limit alcohol healthy nutrition tobacco control d et e r m in a n ts b e h a vi o u r s What works public health can be part of the solution: Investment in prevention reduces health costs and lowers welfare benefits Promoting health and",
      "extractCut": true
    },
    {
      "id": "sec-006-background",
      "number": null,
      "title": "Background",
      "level": 1,
      "pageStart": 11,
      "pageEnd": 13,
      "labelStart": "5",
      "labelEnd": "7",
      "words": 532,
      "summary": {
        "text": "Describes rising pressures on European health systems from noncommunicable diseases, inequalities, ageing, unemployment and climate change. It cites historic gains from tackling causes of disease, such as the fall in tuberculosis deaths through better housing and Finland's North Karelia project, with a chart on contributions of risk factor change to falling heart disease deaths.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "coronary heart",
          "heading": false
        },
        {
          "term": "north karelia",
          "heading": false
        },
        {
          "term": "karelia project",
          "heading": false
        },
        {
          "term": "heart disease",
          "heading": false
        },
        {
          "term": "disease mortality",
          "heading": false
        },
        {
          "term": "blood pressure",
          "heading": false
        },
        {
          "term": "finland",
          "heading": false
        },
        {
          "term": "puska",
          "heading": false
        }
      ],
      "extract": "comparability of many economics studies. In addition, many studies did not record the timescales of returns or may have only examined certain outcomes. In general, investing in early life interventions is estimated to be more cost-effective – see the example of the first 1000 days (Box 1). 6 The case for investing in public health a rising burden of NCDs, increasing inequalities and demographic changes – in",
      "extractCut": true
    },
    {
      "id": "sec-007-the-economic-case-for-prevention",
      "number": null,
      "title": "The economic case for prevention",
      "level": 1,
      "pageStart": 13,
      "pageEnd": 17,
      "labelStart": "7",
      "labelEnd": "11",
      "words": 2310,
      "summary": {
        "text": "Makes the economic case for prevention, arguing that health promotion and disease prevention offer value for money and can produce returns on investment and wider social benefits. It explains primary, secondary and tertiary prevention and argues that upstream population approaches reduce inequalities more effectively. It presents projections of rising public health care spending and estimates of the deaths, illness and costs caused by health inequalities in 25 European countries. The section introduces evidence tables on the cost of inaction and the cost-effectiveness of interventions across health areas.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "noise pollution",
          "heading": false
        },
        {
          "term": "united kingdom",
          "heading": false
        },
        {
          "term": "traffic costs",
          "heading": false
        },
        {
          "term": "billion",
          "heading": false
        },
        {
          "term": "air pollution",
          "heading": false
        },
        {
          "term": "dalys lost",
          "heading": false
        },
        {
          "term": "road traffic",
          "heading": false
        },
        {
          "term": "health inequalities",
          "heading": false
        }
      ],
      "extract": "contributions of changing risk factors, rather than those of specific preventive interventions. Nevertheless, these data demonstrate the significant opportunity for prevention interventions focused on modifying these risk factors. The economic justification is clear. There is good evidence to support an expanded role for health promotion and disease prevention to increase value for money and, for some approaches,",
      "extractCut": true
    },
    {
      "id": "sec-008-the-benefits-of-action",
      "number": null,
      "title": "The benefits of action",
      "level": 1,
      "pageStart": 17,
      "pageEnd": 29,
      "labelStart": "11",
      "labelEnd": "23",
      "words": 4036,
      "summary": {
        "text": "Presents a hierarchy of prevention from business as usual to cost-saving and return-on-investment interventions and a diagram of the report's summary tables. It reproduces WHO \"best buy\" tables by risk factor and by health outcome, with disease burden, cost-effectiveness, implementation cost and feasibility. Further tables summarise cost-effective interventions for resilience, social and environmental determinants, and vaccination and screening. It ends by stressing investment in modern health protection services, including communicable disease control, environmental health and emergency preparedness.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "study timescale",
          "heading": false
        },
        {
          "term": "analysis timescale",
          "heading": false
        },
        {
          "term": "trial timescale",
          "heading": false
        },
        {
          "term": "cost savings",
          "heading": false
        },
        {
          "term": "year savings",
          "heading": false
        },
        {
          "term": "net savings",
          "heading": false
        },
        {
          "term": "dalys averted",
          "heading": false
        },
        {
          "term": "person savings",
          "heading": false
        }
      ],
      "extract": "Fig. 6. A suggested hierarchy of prevention interventions Cost-eﬀective approaches where the ﬁnancial beneﬁts to health and other sectors outweigh the initial investment, giving a return on investment Return on investment Cost-eﬀective approaches that generate additional health (and other) beneﬁts at a cost that society is willing to pay: these will be cost-saving if the additional beneﬁts are generated at a lower",
      "extractCut": true
    },
    {
      "id": "sec-009-conclusions",
      "number": null,
      "title": "Conclusions",
      "level": 1,
      "pageStart": 29,
      "pageEnd": 40,
      "labelStart": "23",
      "labelEnd": "34",
      "words": 4831,
      "summary": {
        "text": "Concludes that interventions on social and environmental determinants, resilience, healthy behaviours, screening and vaccination can be cost-effective, some with returns within one or two years. It warns that cuts to public health services in the European Region risk higher future costs and discusses funding through taxes, insurance and protected budgets. It notes the low per-person cost of WHO's core noncommunicable disease interventions and the benefit of clustering approaches such as safe urban design. The block ends with references and the list of WHO European Region member states.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "accessed september",
          "heading": false
        },
        {
          "term": "economic returns",
          "heading": false
        },
        {
          "term": "economic cost",
          "heading": false
        },
        {
          "term": "perspect public",
          "heading": false
        },
        {
          "term": "economic crisis",
          "heading": false
        },
        {
          "term": "cost effectiveness",
          "heading": false
        },
        {
          "term": "health inequalities",
          "heading": false
        },
        {
          "term": "mental health",
          "heading": false
        }
      ],
      "extract": "interventions targeting the environmental and social determinants of health; those that build resilience, affecting factors such as mental health and violence; those that promote healthy behaviours; and those for screening and vaccination can be cost-effective and give returns on investment in the short and longer term. In particular, theresearchers found a number of interventions with quick returns on investment",
      "extractCut": true
    }
  ],
  "checks": {
    "tocAlignment": {
      "listed_not_found": {
        "count": 0,
        "items": []
      },
      "found_not_listed": {
        "count": 0,
        "items": []
      },
      "page_mismatch": {
        "count": 0,
        "items": []
      }
    },
    "figureSequenceGaps": [],
    "pageLabelConflicts": {
      "count": 0,
      "items": []
    }
  },
  "withheld": false,
  "keywords": [
    {
      "term": "cost-effective health",
      "heading": true
    },
    {
      "term": "cost-effective interventions",
      "heading": true
    },
    {
      "term": "cost billion",
      "heading": false
    },
    {
      "term": "cost-effective approaches",
      "heading": false
    },
    {
      "term": "public health",
      "heading": true
    },
    {
      "term": "mental health",
      "heading": false
    },
    {
      "term": "economic returns",
      "heading": false
    },
    {
      "term": "traffic costs",
      "heading": false
    },
    {
      "term": "environmental health",
      "heading": true
    },
    {
      "term": "health inequalities",
      "heading": false
    },
    {
      "term": "housing interventions",
      "heading": false
    },
    {
      "term": "disease health",
      "heading": false
    }
  ],
  "pageLabels": [
    {
      "physical": 1,
      "label": "1",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 2,
      "label": "2",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 3,
      "label": "i",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 4,
      "label": "ii",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 5,
      "label": "iii",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 6,
      "label": "iv",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 7,
      "label": "1",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 8,
      "label": "2",
      "source": "pdf-labels",
      "confidence": 0.85
    },
    {
      "physical": 9,
      "label": "3",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 10,
      "label": "4",
      "source": "pdf-labels",
      "confidence": 0.85
    },
    {
      "physical": 11,
      "label": "5",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 12,
      "label": "6",
      "source": "pdf-labels",
      "confidence": 0.85
    },
    {
      "physical": 13,
      "label": "7",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 14,
      "label": "8",
      "source": "pdf-labels",
      "confidence": 1
    },
    {
      "physical": 15,
      "label": "9",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 16,
      "label": "10",
      "source": "pdf-labels",
      "confidence": 0.85
    },
    {
      "physical": 17,
      "label": "11",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 18,
      "label": "12",
      "source": "pdf-labels",
      "confidence": 1
    },
    {
      "physical": 19,
      "label": "13",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 20,
      "label": "14",
      "source": "pdf-labels",
      "confidence": 0.85
    },
    {
      "physical": 21,
      "label": "15",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 22,
      "label": "16",
      "source": "pdf-labels",
      "confidence": 0.85
    },
    {
      "physical": 23,
      "label": "17",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 24,
      "label": "18",
      "source": "pdf-labels",
      "confidence": 0.85
    },
    {
      "physical": 25,
      "label": "19",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 26,
      "label": "20",
      "source": "pdf-labels",
      "confidence": 0.85
    },
    {
      "physical": 27,
      "label": "21",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 28,
      "label": "22",
      "source": "pdf-labels",
      "confidence": 1
    },
    {
      "physical": 29,
      "label": "23",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 30,
      "label": "24",
      "source": "pdf-labels",
      "confidence": 0.85
    },
    {
      "physical": 31,
      "label": "25",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 32,
      "label": "26",
      "source": "pdf-labels",
      "confidence": 1
    },
    {
      "physical": 33,
      "label": "27",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 34,
      "label": "28",
      "source": "pdf-labels",
      "confidence": 0.85
    },
    {
      "physical": 35,
      "label": "29",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 36,
      "label": "30",
      "source": "pdf-labels",
      "confidence": 0.85
    },
    {
      "physical": 37,
      "label": "31",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 38,
      "label": "32",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 39,
      "label": "33",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 40,
      "label": "34",
      "source": "pdf-labels",
      "confidence": 0.7
    }
  ],
  "figures": [
    {
      "kind": "figure",
      "number": "1",
      "title": "Cost-effective public health interventions",
      "page": 9,
      "pageLabel": "3",
      "confidence": 0.9,
      "evidence": [
        "referenced",
        "in-sequence",
        "graphic"
      ]
    },
    {
      "kind": "table",
      "number": "1",
      "title": "Summary of interventions found to be cost-effective",
      "page": 10,
      "pageLabel": "4",
      "confidence": 0.8,
      "evidence": [
        "referenced",
        "in-sequence"
      ]
    },
    {
      "kind": "box",
      "number": "1",
      "title": "The importance of the first 1000 days Maternal and child malnutrition in terms of both underand overnutrition are areas for continuing and increasing",
      "page": 11,
      "pageLabel": "5",
      "confidence": 0.8,
      "evidence": [
        "referenced",
        "in-sequence"
      ]
    },
    {
      "kind": "figure",
      "number": "2",
      "title": "Age-adjusted coronary heart disease",
      "page": 12,
      "pageLabel": "6",
      "confidence": 0.9,
      "evidence": [
        "referenced",
        "in-sequence",
        "graphic"
      ]
    },
    {
      "kind": "figure",
      "number": "3",
      "title": "Contribution of treatment and risk factor reduction to global heart disease morbidity",
      "page": 12,
      "pageLabel": "6",
      "confidence": 0.9,
      "evidence": [
        "referenced",
        "in-sequence",
        "graphic"
      ]
    },
    {
      "kind": "figure",
      "number": "4",
      "title": "Levels of prevention",
      "page": 13,
      "pageLabel": "7",
      "confidence": 0.9,
      "evidence": [
        "referenced",
        "in-sequence",
        "graphic"
      ]
    },
    {
      "kind": "figure",
      "number": "5",
      "title": "OECD projections for public spending on health care 2005–2050",
      "page": 14,
      "pageLabel": "8",
      "confidence": 0.7,
      "evidence": [
        "in-sequence",
        "graphic"
      ]
    },
    {
      "kind": "table",
      "number": "2a",
      "title": "Costs of not acting: health outcomes",
      "page": 15,
      "pageLabel": "9",
      "confidence": 0.7,
      "evidence": [
        "referenced"
      ]
    },
    {
      "kind": "table",
      "number": "2b",
      "title": "Costs of not acting: risk factors",
      "page": 16,
      "pageLabel": "10",
      "confidence": 0.5,
      "evidence": []
    },
    {
      "kind": "figure",
      "number": "6",
      "title": "A suggested hierarchy of prevention interventions",
      "page": 17,
      "pageLabel": "11",
      "confidence": 0.9,
      "evidence": [
        "referenced",
        "in-sequence",
        "graphic"
      ]
    },
    {
      "kind": "figure",
      "number": "7",
      "title": "Conceptual diagram of the summary tables",
      "page": 18,
      "pageLabel": "12",
      "confidence": 0.9,
      "evidence": [
        "referenced",
        "in-sequence",
        "graphic"
      ]
    },
    {
      "kind": "table",
      "number": "3a",
      "title": "“Best buy” interventions by risk factor",
      "page": 19,
      "pageLabel": "13",
      "confidence": 0.7,
      "evidence": [
        "referenced"
      ]
    },
    {
      "kind": "table",
      "number": "3b",
      "title": "“Best buy” interventions by health outcome",
      "page": 20,
      "pageLabel": "14",
      "confidence": 0.7,
      "evidence": [
        "referenced"
      ]
    },
    {
      "kind": "table",
      "number": "4a",
      "title": "Cost-effective interventions to build resilience: factors affecting health behaviours and outcomes",
      "page": 22,
      "pageLabel": "16",
      "confidence": 0.7,
      "evidence": [
        "referenced"
      ]
    },
    {
      "kind": "table",
      "number": "4b",
      "title": "Cost-effective interventions to address social determinants of health",
      "page": 24,
      "pageLabel": "18",
      "confidence": 0.7,
      "evidence": [
        "referenced"
      ]
    },
    {
      "kind": "table",
      "number": "4c",
      "title": "Cost-effective interventions to address environmental determinants of health",
      "page": 25,
      "pageLabel": "19",
      "confidence": 0.7,
      "evidence": [
        "referenced"
      ]
    },
    {
      "kind": "table",
      "number": "4d",
      "title": "Cost-effective interventions for vaccination and screening",
      "page": 27,
      "pageLabel": "21",
      "confidence": 0.7,
      "evidence": [
        "referenced"
      ]
    }
  ],
  "images": [
    {
      "id": "img-p001-1",
      "file": "images/img-p001-1.webp",
      "page": 1,
      "narratives": {
        "en": "Cover photograph of green seedlings sprouting from mounds of soil placed on stacks of gold-coloured coins of different heights.",
        "ar": "صورة الغلاف لشتلات خضراء تنبت من أكوام من التربة موضوعة على رزم من العملات المعدنية ذهبية اللون بارتفاعات مختلفة.",
        "zh": "封面照片：绿色幼苗从放在不同高度金色硬币堆上的土堆中长出。",
        "es": "Fotografía de portada de plántulas verdes que brotan de montículos de tierra colocados sobre pilas de monedas doradas de distintas alturas.",
        "fr": "Photographie de couverture de jeunes pousses vertes sortant de petits tas de terre posés sur des piles de pièces dorées de différentes hauteurs.",
        "ru": "Фотография на обложке: зеленые ростки, пробивающиеся из горок земли на стопках монет золотистого цвета разной высоты."
      },
      "state": "draft"
    },
    {
      "id": "img-p001-2",
      "file": "images/img-p001-2.webp",
      "page": 1,
      "narratives": {
        "en": "Cover photograph of a large group of young people in casual clothes standing in a circle and holding hands, on a white background.",
        "ar": "صورة الغلاف لمجموعة كبيرة من الشباب بملابس غير رسمية يقفون في دائرة ويمسكون بأيدي بعضهم، على خلفية بيضاء.",
        "zh": "封面照片：一大群身穿便装的年轻人站成一圈手拉着手，白色背景。",
        "es": "Fotografía de portada de un gran grupo de jóvenes con ropa informal de pie en círculo y tomados de la mano, sobre fondo blanco.",
        "fr": "Photographie de couverture d’un grand groupe de jeunes en tenue décontractée, debout en cercle et se tenant par la main, sur fond blanc.",
        "ru": "Фотография на обложке: большая группа молодых людей в повседневной одежде стоит в кругу, взявшись за руки, на белом фоне."
      },
      "state": "draft"
    },
    {
      "id": "img-p001-3",
      "file": "images/img-p001-3.webp",
      "page": 1,
      "narratives": {
        "en": "Cover photograph of a large red apple behind a row of coin stacks that decrease in height from left to right.",
        "ar": "صورة الغلاف لتفاحة حمراء كبيرة خلف صف من رزم العملات المعدنية يتناقص ارتفاعها من اليسار إلى اليمين.",
        "zh": "封面照片：一个大红苹果，前方是一排从左到右逐渐变矮的硬币堆。",
        "es": "Fotografía de portada de una gran manzana roja detrás de una fila de pilas de monedas que disminuyen de altura de izquierda a derecha.",
        "fr": "Photographie de couverture d’une grosse pomme rouge derrière une rangée de piles de pièces de hauteur décroissante de gauche à droite.",
        "ru": "Фотография на обложке: крупное красное яблоко за рядом стопок монет, высота которых уменьшается слева направо."
      },
      "state": "draft"
    },
    {
      "id": "vfig-p009",
      "file": "figures/vfig-p009.webp",
      "page": 9,
      "shows": [
        "Figure 1"
      ],
      "narratives": {
        "en": "Infographic (Fig. 1, Cost-effective public health interventions) headed 'Public health can be part of the solution' and 'What works', drawn as a bicycle. The rear wheel, 'Determinants', is divided into Green Space, Employment, Housing, Transport and Environment; the front wheel, 'Behaviours', into Physical Activity, Mental Health, Violence Prevention, Limit Alcohol, Tobacco Control and Healthy Nutrition. The road beneath is labelled 'Disease prevention: Vaccination and screening'.",
        "ar": "رسم معلوماتي (الشكل 1، تدخلات الصحة العامة الفعالة من حيث التكلفة) بعنوان «يمكن أن تكون الصحة العامة جزءًا من الحل» و«ما الذي ينجح»، مرسوم على شكل دراجة. تنقسم العجلة الخلفية، «المحددات»، إلى المساحات الخضراء والعمالة والإسكان والنقل والبيئة؛ وتنقسم العجلة الأمامية، «السلوكيات»، إلى النشاط البدني والصحة النفسية والوقاية من العنف والحد من الكحول ومكافحة التبغ والتغذية الصحية. ويحمل الطريق أسفلها عنوان «الوقاية من الأمراض: التطعيم والتحري».",
        "zh": "信息图（图1，具有成本效益的公共卫生干预措施），标题为“公共卫生可以成为解决方案的一部分”和“有效措施”，画成一辆自行车。后轮“决定因素”分为绿地、就业、住房、交通和环境；前轮“行为”分为身体活动、精神卫生、暴力预防、限制饮酒、烟草控制和健康营养。下方道路标注为“疾病预防：疫苗接种和筛查”。",
        "es": "Infografía (fig. 1, Intervenciones de salud pública costoeficaces) titulada «La salud pública puede ser parte de la solución» y «Lo que funciona», representada como una bicicleta. La rueda trasera, «Determinantes», se divide en espacios verdes, empleo, vivienda, transporte y medio ambiente; la delantera, «Comportamientos», en actividad física, salud mental, prevención de la violencia, limitar el alcohol, control del tabaco y nutrición saludable. La carretera inferior lleva el rótulo «Prevención de enfermedades: vacunación y cribado».",
        "fr": "Infographie (fig. 1, Interventions de santé publique coût-efficaces) intitulée « La santé publique peut faire partie de la solution » et « Ce qui fonctionne », dessinée sous forme de bicyclette. La roue arrière, « Déterminants », est divisée en espaces verts, emploi, logement, transports et environnement ; la roue avant, « Comportements », en activité physique, santé mentale, prévention de la violence, limitation de l’alcool, lutte antitabac et alimentation saine. La route en dessous porte la mention « Prévention des maladies : vaccination et dépistage ».",
        "ru": "Инфографика (рис. 1, Затратоэффективные меры общественного здравоохранения) с заголовками «Общественное здравоохранение может стать частью решения» и «Что работает» в виде велосипеда. Заднее колесо, «Детерминанты», разделено на секторы: зеленые зоны, занятость, жилье, транспорт и окружающая среда; переднее, «Поведение», — физическая активность, психическое здоровье, профилактика насилия, ограничение алкоголя, борьба против табака и здоровое питание. Дорога внизу подписана «Профилактика заболеваний: вакцинация и скрининг»."
      },
      "state": "draft"
    },
    {
      "id": "vfig-p012",
      "file": "figures/vfig-p012.webp",
      "page": 12,
      "shows": [
        "Figure 2",
        "Figure 3"
      ],
      "narratives": {
        "en": "Cropped page render with two charts. A line chart (Fig. 2) shows coronary heart disease mortality per 100 000 population from 1969 to the early 2000s for North Karelia (green) and All Finland (black), with markers for the start of the North Karelia Project and its national extension; both lines fall steeply, by about 85% and 80% respectively. Below, part of a horizontal stacked bar chart (Fig. 3) shows three segments per row (e.g. 40/54/6, 24/76/0), but its row labels and legend are cut off.",
        "ar": "صفحة مقتطعة تضم مخططين. يبيّن مخطط خطي (الشكل 2) معدل الوفيات الناجمة عن مرض القلب التاجي لكل 100 000 نسمة من عام 1969 إلى أوائل الألفية الثانية في كاريليا الشمالية (بالأخضر) وفنلندا كلها (بالأسود)، مع علامتين لبدء مشروع كاريليا الشمالية وتوسيعه على الصعيد الوطني؛ وينخفض الخطان انخفاضًا حادًا، بنحو 85% و80% على التوالي. وفي الأسفل جزء من مخطط شريطي أفقي مكدّس (الشكل 3) يضم ثلاثة أجزاء في كل صف (مثل 40/54/6 و24/76/0)، لكن تسميات الصفوف ومفتاح الألوان مقطوعة.",
        "zh": "截取的页面，含两张图表。折线图（图2）显示1969年至21世纪初北卡累利阿（绿色）和芬兰全国（黑色）每10万人口冠心病死亡率，并标注北卡累利阿项目启动及推广至全国的时间点；两条曲线均大幅下降，分别约85%和80%。下方为横向堆积条形图（图3）的一部分，每行分三段（如40/54/6、24/76/0），但行标签和图例被截去。",
        "es": "Representación recortada de una página con dos gráficos. Un gráfico de líneas (fig. 2) muestra la mortalidad por cardiopatía coronaria por 100 000 habitantes desde 1969 hasta principios de los años 2000 en Carelia del Norte (verde) y en toda Finlandia (negro), con marcas del inicio del Proyecto Carelia del Norte y de su extensión nacional; ambas líneas descienden marcadamente, alrededor de un 85% y un 80%, respectivamente. Debajo, parte de un gráfico de barras horizontales apiladas (fig. 3) con tres segmentos por fila (p. ej., 40/54/6, 24/76/0), pero sus etiquetas de fila y su leyenda están cortadas.",
        "fr": "Rendu recadré d’une page avec deux graphiques. Un graphique linéaire (fig. 2) montre la mortalité par cardiopathie coronarienne pour 100 000 habitants de 1969 au début des années 2000 en Carélie du Nord (vert) et dans l’ensemble de la Finlande (noir), avec des repères pour le début du projet Carélie du Nord et son extension nationale ; les deux courbes baissent fortement, d’environ 85 % et 80 % respectivement. En dessous, une partie d’un graphique à barres horizontales empilées (fig. 3) montre trois segments par ligne (p. ex. 40/54/6, 24/76/0), mais les libellés des lignes et la légende sont coupés.",
        "ru": "Обрезанный фрагмент страницы с двумя диаграммами. Линейный график (рис. 2) показывает смертность от ишемической болезни сердца на 100 000 населения с 1969 г. до начала 2000-х гг. в Северной Карелии (зеленый) и по всей Финляндии (черный) с отметками начала проекта «Северная Карелия» и его распространения на всю страну; обе линии резко снижаются — примерно на 85% и 80% соответственно. Ниже — часть горизонтальной столбчатой диаграммы с накоплением (рис. 3) с тремя сегментами в каждой строке (например, 40/54/6, 24/76/0), но подписи строк и легенда обрезаны."
      },
      "state": "draft"
    },
    {
      "id": "vfig-p013",
      "file": "figures/vfig-p013.webp",
      "page": 13,
      "shows": [
        "Figure 4"
      ],
      "narratives": {
        "en": "Diagram of levels of prevention (Fig. 4) as three stacked coloured boxes. Primary prevention (blue) promotes population health and prevents disease before it occurs, an 'upstream approach'; secondary prevention (orange) detects disease and risk factors early, e.g. screening; tertiary prevention (red) treats disease to slow or reverse progression, including rehabilitation, a 'downstream approach'.",
        "ar": "مخطط لمستويات الوقاية (الشكل 4) في صورة ثلاثة مربعات ملونة متراصة. الوقاية الأولية (بالأزرق) تعزز صحة السكان وتقي من المرض قبل حدوثه، وهي «نهج المنبع»؛ والوقاية الثانوية (بالبرتقالي) تكشف المرض وعوامل الخطر مبكرًا، مثل التحري؛ والوقاية الثالثية (بالأحمر) تعالج المرض لإبطاء تطوره أو عكسه، بما في ذلك إعادة التأهيل، وهي «نهج المصب».",
        "zh": "预防层级示意图（图4），由三个上下排列的彩色方框组成。一级预防（蓝色）促进人群健康并在疾病发生前加以预防，被视为“上游方法”；二级预防（橙色）及早发现疾病和风险因素，如筛查；三级预防（红色）治疗疾病以减缓或逆转进展，包括康复，被视为“下游方法”。",
        "es": "Diagrama de los niveles de prevención (fig. 4) en tres recuadros de colores apilados. La prevención primaria (azul) promueve la salud de la población y previene la enfermedad antes de que ocurra, un «enfoque preventivo inicial»; la secundaria (naranja) detecta precozmente la enfermedad y los factores de riesgo, p. ej., mediante cribado; la terciaria (rojo) trata la enfermedad para frenar o revertir su progresión, incluida la rehabilitación, un «enfoque correctivo final».",
        "fr": "Schéma des niveaux de prévention (fig. 4) en trois encadrés colorés superposés. La prévention primaire (bleu) promeut la santé de la population et prévient la maladie avant qu’elle survienne, une « approche en amont » ; la prévention secondaire (orange) détecte tôt la maladie et les facteurs de risque, p. ex. par le dépistage ; la prévention tertiaire (rouge) traite la maladie pour ralentir ou inverser sa progression, y compris la réadaptation, une « approche en aval ».",
        "ru": "Схема уровней профилактики (рис. 4) в виде трех цветных блоков друг под другом. Первичная профилактика (синий) укрепляет здоровье населения и предупреждает болезнь до ее возникновения — «подход на входе»; вторичная (оранжевый) выявляет болезнь и факторы риска на ранней стадии, например скрининг; третичная (красный) лечит болезнь, чтобы замедлить или обратить ее прогрессирование, включая реабилитацию, — «подход на выходе»."
      },
      "state": "draft"
    },
    {
      "id": "vfig-p017",
      "file": "figures/vfig-p017.webp",
      "page": 17,
      "shows": [
        "Figure 6"
      ],
      "narratives": {
        "en": "Diagram of a suggested hierarchy of prevention interventions (Fig. 6) with three coloured labels and definitions: Return on investment (blue), where financial benefits to health and other sectors outweigh the initial investment; Cost saving (orange), where additional benefits come at a cost society is willing to pay and lower than usual practice; and Cost pressure/business as usual (red), continued current practice with rising health care costs.",
        "ar": "مخطط للتسلسل الهرمي المقترح لتدخلات الوقاية (الشكل 6) بثلاث تسميات ملونة مع تعريفاتها: العائد على الاستثمار (بالأزرق)، حيث تفوق المنافع المالية للصحة والقطاعات الأخرى الاستثمار الأولي؛ وتوفير التكاليف (بالبرتقالي)، حيث تتحقق منافع إضافية بتكلفة يقبلها المجتمع وأقل من الممارسة المعتادة؛ وضغط التكاليف/استمرار الوضع الراهن (بالأحمر)، أي استمرار الممارسة الحالية مع ارتفاع تكاليف الرعاية الصحية.",
        "zh": "建议的预防干预措施层级示意图（图6），包含三个彩色标签及其定义：投资回报（蓝色），即对卫生和其他部门的财务收益超过初始投资；节约成本（橙色），即以社会愿意支付且低于常规做法的成本产生额外收益；成本压力/一切照旧（红色），即继续现行做法，卫生保健费用不断上升。",
        "es": "Diagrama de una jerarquía sugerida de intervenciones de prevención (fig. 6) con tres etiquetas de colores y sus definiciones: rendimiento de la inversión (azul), cuando los beneficios financieros para la salud y otros sectores superan la inversión inicial; ahorro de costos (naranja), cuando los beneficios adicionales se obtienen a un costo que la sociedad está dispuesta a pagar e inferior al de la práctica habitual; y presión de costos/statu quo (rojo), continuación de la práctica actual con costos de atención de salud crecientes.",
        "fr": "Schéma d’une hiérarchie proposée des interventions de prévention (fig. 6) avec trois étiquettes colorées et leurs définitions : retour sur investissement (bleu), lorsque les bénéfices financiers pour la santé et les autres secteurs dépassent l’investissement initial ; économies (orange), lorsque des bénéfices supplémentaires sont obtenus à un coût que la société est prête à payer et inférieur à la pratique habituelle ; pression sur les coûts/statu quo (rouge), poursuite de la pratique actuelle avec des coûts de soins croissants.",
        "ru": "Схема предлагаемой иерархии профилактических мер (рис. 6) с тремя цветными метками и определениями: окупаемость инвестиций (синий), когда финансовые выгоды для здравоохранения и других секторов превышают первоначальные вложения; экономия затрат (оранжевый), когда дополнительные выгоды достигаются по цене, приемлемой для общества и ниже обычной практики; давление затрат/обычная практика (красный) — продолжение текущей практики с ростом расходов на здравоохранение."
      },
      "state": "draft"
    },
    {
      "id": "vfig-p018",
      "file": "figures/vfig-p018.webp",
      "page": 18,
      "shows": [
        "Figure 7"
      ],
      "narratives": {
        "en": "Conceptual diagram of the summary tables (Fig. 7). On the left, boxes 2a 'Costs of not acting: health outcomes' and 2b 'Costs of not acting: risk factors'; an orange arrow labelled 'Potential solutions' points to boxes 3a '\"Best buy\" interventions by risk factor' (tobacco, alcohol, diet, physical inactivity, infection), 3b '\"Best buy\" interventions by health outcome' (CVD and diabetes, cancer, respiratory disease), 4a resilience (violence and abuse, mental health), 4b social determinants (housing, debt, employment), 4c environmental determinants (road traffic injuries, green space, climate, active transport, environmental hazards) and 4d vaccination and screening.",
        "ar": "مخطط مفاهيمي للجداول الموجزة (الشكل 7). على اليسار المربعان 2a «تكاليف عدم التحرك: النتائج الصحية» و2b «تكاليف عدم التحرك: عوامل الخطر»؛ ويشير سهم برتقالي بعنوان «الحلول المحتملة» إلى المربعات 3a «تدخلات \"أفضل الصفقات\" حسب عامل الخطر» (التبغ، الكحول، النظام الغذائي، الخمول البدني، العدوى)، و3b «تدخلات \"أفضل الصفقات\" حسب الحصيلة الصحية» (أمراض القلب والأوعية الدموية والسكري، السرطان، أمراض الجهاز التنفسي)، و4a بناء القدرة على الصمود (العنف والإساءة، الصحة النفسية)، و4b المحددات الاجتماعية (الإسكان، الديون، العمالة)، و4c المحددات البيئية (الإصابات الناجمة عن حوادث المرور، المساحات الخضراء، المناخ، النقل النشط، المخاطر البيئية)، و4d التطعيم والتحري.",
        "zh": "汇总表概念图（图7）。左侧为方框2a“不采取行动的代价：健康结果”和2b“不采取行动的代价：风险因素”；标注“潜在解决方案”的橙色箭头指向方框3a“按风险因素划分的‘最合算’干预措施”（烟草、酒精、饮食、缺乏身体活动、感染）、3b“按健康结果划分的‘最合算’干预措施”（心血管疾病和糖尿病、癌症、呼吸系统疾病）、4a增强抵御能力（暴力和虐待、精神卫生）、4b社会决定因素（住房、债务、就业）、4c环境决定因素（道路交通伤害、绿地、气候、积极出行、环境危害）和4d疫苗接种和筛查。",
        "es": "Diagrama conceptual de los cuadros resumen (fig. 7). A la izquierda, los recuadros 2a «Costos de no actuar: resultados de salud» y 2b «Costos de no actuar: factores de riesgo»; una flecha naranja rotulada «Posibles soluciones» apunta a los recuadros 3a «Intervenciones \"más costoeficaces\" por factor de riesgo» (tabaco, alcohol, dieta, inactividad física, infección), 3b «Intervenciones \"más costoeficaces\" por resultado de salud» (ECV y diabetes, cáncer, enfermedades respiratorias), 4a resiliencia (violencia y maltrato, salud mental), 4b determinantes sociales (vivienda, deuda, empleo), 4c determinantes ambientales (traumatismos causados por el tránsito, espacios verdes, clima, transporte activo, riesgos ambientales) y 4d vacunación y cribado.",
        "fr": "Schéma conceptuel des tableaux récapitulatifs (fig. 7). À gauche, les encadrés 2a « Coûts de l’inaction : résultats sanitaires » et 2b « Coûts de l’inaction : facteurs de risque » ; une flèche orange intitulée « Solutions possibles » pointe vers les encadrés 3a « Interventions les plus rentables par facteur de risque » (tabac, alcool, alimentation, sédentarité, infection), 3b « Interventions les plus rentables par résultat sanitaire » (MCV et diabète, cancer, maladies respiratoires), 4a résilience (violence et maltraitance, santé mentale), 4b déterminants sociaux (logement, dette, emploi), 4c déterminants environnementaux (traumatismes dus aux accidents de la route, espaces verts, climat, transports actifs, risques environnementaux) et 4d vaccination et dépistage.",
        "ru": "Концептуальная схема сводных таблиц (рис. 7). Слева блоки 2a «Издержки бездействия: показатели здоровья» и 2b «Издержки бездействия: факторы риска»; оранжевая стрелка с подписью «Возможные решения» указывает на блоки 3a «Наиболее выгодные меры по факторам риска» (табак, алкоголь, питание, недостаточная физическая активность, инфекции), 3b «Наиболее выгодные меры по исходам для здоровья» (ССЗ и диабет, рак, болезни органов дыхания), 4a повышение жизнестойкости (насилие и жестокое обращение, психическое здоровье), 4b социальные детерминанты (жилье, долги, занятость), 4c экологические детерминанты (дорожно-транспортный травматизм, зеленые зоны, климат, активные виды транспорта, экологические опасности) и 4d вакцинация и скрининг."
      },
      "state": "draft"
    }
  ],
  "tables": [
    {
      "label": "Table 1",
      "caption": "Table 1. Summary of interventions found to be cost-effective",
      "pages": [
        10
      ],
      "columns": [
        {
          "titles": "Intervention focus"
        },
        {
          "titles": "Quick wins (0–5 years)"
        },
        {
          "titles": "Longer-term gains (over 5 years)"
        }
      ],
      "rows": [
        [
          "Environmental determinants",
          "• Road traffic injury preventiona • Active transporta • Safe green spacesa • Heat wave plana",
          "• Removal of lead and mercury • Chemical regulation"
        ],
        [
          "Social determinants",
          "• Healthy employment programmes • Insulating homesa • Housing ventilation for asthma • Community falls prevention",
          "–"
        ],
        [
          "Resilience",
          "• Violence prevention legislation • Prevention of postnatal depression • Family support projects • Social emotional learning • Bullying prevention • Mental health in the workplace • Psychosocial groups for older people • Parenting programmes • Depression prevention",
          "• Preschool programmes • Prevention of conduct disorder • Multisystemic therapy for juvenile offenders • Detection of and care for the victims of intimate partner violence"
        ],
        [
          "Behaviour",
          "• Lifestyle diabetes prevention programmea • Restricting alcohol availability • Community-based youth tobacco control intervention • Workplace obesity intervention • Tobacco legislation, taxation and control (WHO very cost-effective) • Alcohol legislation, taxation and control (WHO very cost-effective) • Nutrition – reducing salt; replacing trans fatty acids; raising public awareness of healthy dietsa (WHO very cost-effective) • Physical activity mass media awareness (WHO very cost-effective)",
          "• Alcohol minimum price • Counselling to smokers (WHO quite cost-effective) • Alcohol brief interventions and alcohol driving breath tests (WHO quite cost-effective)"
        ],
        [
          "Vaccination",
          "• For children: norovirus, pneumococcus, rotavirus, influenza",
          "• Influenza, pneumococcus • Measles, mumps and rubella; diphtheria, pertussis and tetanus • Human papillomavirus; hepatitis B; meningitis C"
        ],
        [
          "Screening",
          "• Screening for abdominal aortic aneurysm • Screening for depression in diabetes • Cervical cancer screening (WHO very cost-effective)",
          "• Screening for diabetes and impaired glucose tolerance • Vascular disease health checks • Breast and colon cancer screening (WHO quite cost-effective)"
        ],
        [
          "Treatment",
          "• Treatment of depression in diabetes patients • Treatment ofCVD (WHO very cost-effective)",
          "• Treatment of diabetes (WHO quite cost-effective) • Treatment of asthma (WHO quite cost-effective)"
        ]
      ],
      "notes": "Key: Green: offers a return on investment. Orange: cost-effective. Black: WHO “best buy” interventions – timescales and costs not included; please note that these calculations were performed for low- and middle-income countries. a “win win win” approaches with multiple health, social and environmental benefits: these have been shown to be cost-effective, with potential returns on investment within five years; they also contribute to wider aspects of sustainability, including economic, social and environmental benefits (Bone and Nurse, 2010). [Colour coding of items is not preserved in the cells. Orange (cost-effective) items: Housing ventilation for asthma; Community falls prevention; Parenting programmes; Depression prevention; Multisystemic therapy for juvenile offenders; Detection of and care for the victims of intimate partner violence; Community-based youth tobacco control intervention; Workplace obesity intervention; Human papillomavirus; hepatitis B; meningitis C; Screening for diabetes and impaired glucose tolerance; Vascular disease health checks; Treatment of depression in diabetes patients. Black items are those marked \"(WHO very/quite cost-effective)\"; all other items are green.]",
      "narratives": {
        "en": "Cost-effective public health interventions grouped by focus (environmental and social determinants, resilience, behaviour, vaccination, screening, treatment) and by whether they are quick wins (0–5 years) or longer-term gains (over 5 years). Colour coding distinguishes interventions offering a return on investment, cost-effective ones and WHO “best buys”.",
        "ar": "تدخلات الصحة العامة العالية المردودية مصنفة بحسب مجال التركيز (المحددات البيئية والاجتماعية، والقدرة على الصمود، والسلوك، والتطعيم، والفحص، والعلاج) وبحسب ما إذا كانت مكاسب سريعة (0–5 سنوات) أو مكاسب أطول أجلاً (أكثر من 5 سنوات). ويميّز الترميز اللوني بين التدخلات التي تحقق عائداً على الاستثمار، والتدخلات العالية المردودية، و\"أفضل الخيارات\" التي حددتها المنظمة.",
        "zh": "按重点领域（环境和社会决定因素、复原力、行为、疫苗接种、筛查、治疗）以及属于短期见效（0–5年）还是长期收益（5年以上）分组列出的具有成本效益的公共卫生干预措施。颜色编码区分了可带来投资回报的干预措施、具有成本效益的措施和世卫组织“最合算措施”。",
        "es": "Intervenciones de salud pública costoeficaces agrupadas por ámbito (determinantes ambientales y sociales, resiliencia, comportamiento, vacunación, cribado, tratamiento) y según sean beneficios rápidos (0-5 años) o a más largo plazo (más de 5 años). Un código de colores distingue las intervenciones con retorno de la inversión, las costoeficaces y las «mejores inversiones» de la OMS.",
        "fr": "Interventions de santé publique coût-efficaces regroupées par domaine (déterminants environnementaux et sociaux, résilience, comportements, vaccination, dépistage, traitement) et selon qu’elles produisent des gains rapides (0-5 ans) ou à plus long terme (plus de 5 ans). Un code couleur distingue les interventions offrant un retour sur investissement, celles qui sont coût-efficaces et les « meilleurs choix » de l’OMS.",
        "ru": "Экономически эффективные меры общественного здравоохранения, сгруппированные по направлению (экологические и социальные детерминанты, жизнестойкость, поведение, вакцинация, скрининг, лечение) и по сроку отдачи: быстрые результаты (0–5 лет) или долгосрочные выгоды (более 5 лет). Цветом выделены меры, обеспечивающие окупаемость инвестиций, экономически эффективные меры и «наиболее выгодные» меры ВОЗ."
      },
      "csv": "tables/table-1.csv"
    },
    {
      "label": "Table 2a",
      "caption": "Table 2a. Costs of not acting: health outcomes",
      "pages": [
        15
      ],
      "columns": [
        {
          "titles": "Health topic"
        },
        {
          "titles": "DALYs lost in Europe (millions)a"
        },
        {
          "titles": "Costs at the individual level"
        },
        {
          "titles": "Costs to health sectors"
        },
        {
          "titles": "Costs to governments/ wider society"
        }
      ],
      "rows": [
        [
          "CVD",
          "36.4",
          "–",
          "–",
          "€169 billion per year in the EU (Leal et al., 2006)"
        ],
        [
          "Mental health",
          "28.9",
          "Annual cost to society of mental illness in childhood: £11–59 000 per child (United Kingdom) (Suhrcke et al., 2007) Costs for children with severe and complex mental health problems: over £1000 per week (United Kingdom) (Clarke et al., 2005)",
          "10.48% of 2008/9 National Health Service (NHS) budget spent on mental health services (United Kingdom) (Department of Health, 2012) Cost of depression: £1.7 billion in 2007 (United Kingdom) (McCrone et al., 2008) Cost of anxiety disorders: £1.2 billion in 2007 (United Kingdom) (McCrone et al., 2008)",
          "£110 billion per year in the United Kingdom (McCrone et al., 2008; Friedli& Parsonage, 2007)"
        ],
        [
          "Cancer",
          "17.0",
          "–",
          "6.5% of health care expenditure in the EU (Stark, 2006)",
          "€117 billion per year in the EU (Luengo-Fernandez et al., 2012)"
        ],
        [
          "Communicable disease",
          "15.9",
          "–",
          "Each unplanned influenza admission costs the NHS £347–774 (United Kingdom) (Department of Health, 2010) The measles epidemic cost the NHS £433 000–995 000 over the two-year period 2008/9 (United Kingdom) (Department of Health, 2010)",
          "Influenza cost the economy £6.75 billion in 1999 (United Kingdom) (Voelker, 1999)"
        ],
        [
          "Road traffic injuries",
          "3.6",
          "–",
          "–",
          "Up to 2% of GDP in middle- and high-income countries in the EU (Racioppi et al., 2004) Road traffic collisions cost €153 billion per yearin the EU (Racioppi et al., 2004)"
        ],
        [
          "Diabetes",
          "2.6",
          "–",
          "Cost to the NHS: £1.3 billion per year (United Kingdom) (Wanless, 2002)",
          "–"
        ],
        [
          "Violence",
          "1.9",
          "Around DKr 65 000 per female victim of violence (Denmark) (Helweg-Larsen et al., 2010)",
          "In 2007, violence cost the NHS an estimated £2 billion (United Kingdom) (Home Office, 2009) Annual costs for the immediate treatment of injuries resulting from violent assaults: nearly DKr 11 million (Denmark) (Helweg-Larsen et al., 2010)",
          "Violence costs the economy in England and Wales over £40.1 billion per year (United Kingdom) (Home Office, 2009) Violence against women costs Danish society approximately DKr 500 million (about €70 million) per year (Denmark) (Helweg-Larsen et al., 2010)"
        ]
      ],
      "notes": "a DALYs include 3% discounting and age weights.",
      "narratives": {
        "en": "For seven health outcomes (CVD, mental health, cancer, communicable disease, road traffic injuries, diabetes, violence), the table gives DALYs lost in Europe and examples, with sources, of costs at the individual level, to health sectors and to governments or wider society.",
        "ar": "يعرض الجدول، لسبع حصائل صحية (أمراض القلب والأوعية الدموية، والصحة النفسية، والسرطان، والأمراض السارية، وإصابات حوادث المرور، والسكري، والعنف)، سنوات العمر المصححة باحتساب مدد العجز المفقودة في أوروبا، وأمثلة موثقة المصادر على التكاليف على مستوى الأفراد والقطاعات الصحية والحكومات أو المجتمع الأوسع.",
        "zh": "该表针对七种健康结局（心血管疾病、精神卫生、癌症、传染病、道路交通伤害、糖尿病、暴力）列出欧洲损失的伤残调整生命年，以及个人层面、卫生部门和政府或更广泛社会所承担费用的示例及其来源。",
        "es": "Para siete resultados de salud (ECV, salud mental, cáncer, enfermedades transmisibles, traumatismos por accidentes de tránsito, diabetes, violencia), el cuadro presenta los AVAD perdidos en Europa y ejemplos, con sus fuentes, de los costos para las personas, para el sector de la salud y para los gobiernos o la sociedad en general.",
        "fr": "Pour sept problèmes de santé (MCV, santé mentale, cancer, maladies transmissibles, traumatismes dus aux accidents de la route, diabète, violence), le tableau présente les DALY perdues en Europe et des exemples sourcés des coûts pour les individus, pour les secteurs de la santé et pour les pouvoirs publics ou la société.",
        "ru": "По семи исходам для здоровья (ССЗ, психическое здоровье, рак, инфекционные болезни, дорожно-транспортный травматизм, диабет, насилие) в таблице приведены потерянные в Европе DALY и примеры (с источниками) затрат на индивидуальном уровне, для сектора здравоохранения и для государства или общества в целом."
      },
      "csv": "tables/table-2a.csv"
    },
    {
      "label": "Table 2b",
      "caption": "Table 2b. Costs of not acting: risk factors",
      "pages": [
        16
      ],
      "columns": [
        {
          "titles": "Health topic"
        },
        {
          "titles": "DALYs lost in Europe (millions)a"
        },
        {
          "titles": "Costs at the individual level"
        },
        {
          "titles": "Costs to health sectors"
        },
        {
          "titles": "Costs to governments/ wider society"
        }
      ],
      "rows": [
        [
          "Tobacco",
          "17.7",
          "The average smoker spends two months’ wages per year on cigarettes (Albania) (Viscusi&Hersch, 2008) Private mortality costs per packet: US$ 222 (men) and US$ 94 (women) (United States) (Viscusi&Hersch, 2008)",
          "Smoking-related conditions cost the NHS more than £5 billion per year (United Kingdom) (University of Oxford, 2009)",
          "US$ 500 billion per year to the global economy(Shafey et al., 2009) Tobacco use reduces overall national incomes by up to 3.6% (Shafey et al., 2009)"
        ],
        [
          "Harmful alcohol use",
          "17.3",
          "Heavy drinking increases the risk of unemployment, absenteeism, and presenteeism (attending work while sick) (Anderson et al., 2012)",
          "Alcohol-use disorders cost the NHS £2.9 billion per year (United Kingdom)(NICE, 2010)",
          "Effects on health, well-being and productivity reach US$ 300–400 purchasing power parity per capita per year (Rehm et al., 2009) Alcohol-related harm costs £20–55 billion per year (United Kingdom)(PMS Unit, 2004) Alcohol cost the EU €125 billion in 2003 (1.3% of GDP) (Anderson &Baumberg, 2006)"
        ],
        [
          "Unhealthy diet",
          "15.3",
          "Obese individuals incur health expenditure more than 30% higher than those of normal weight(Withrow& Alter, 2011)",
          "Obesity accounts for 0.7–2.8% of total health expenditure in most countries (Withrow& Alter, 2011)",
          "Obesity accounts for 1–3% of GDP in most countries, but is as high as 5–10% of GDP in the United States (Sassi, 2010)"
        ],
        [
          "Physical inactivity",
          "8.2",
          "Inactive Danish men lose three days of work compared to moderately active men (Juel et al., 2008) Lack of physical activity could account for 8% of all social disability pensions in Denmark (Juel et al., 2008)",
          "Globally physical inactivity accounts for 1.5–3% of national health care budgets (Oldridge, 2008) Physical inactivity accounted for 2.9% of total health expenditure in 2000 (Denmark) (Juel et al., 2008) Direct medical costs to the NHS: £1.06 billion (United Kingdom) (Allender et al., 2007)",
          "Physical inactivity is estimated to cost €150–300 per inhabitant per year in Europe(Cavill et al., 2006)"
        ],
        [
          "Environmental risks",
          "2.5 (includes occupational risks, urban outdoor air pollution, unsafe water, sanitation, hygiene, indoor smoke from solid fuels, lead exposure and global climate change)",
          "An estimated total of 1087 potential years of life lost in 2005 (Switzerland)(FOEN, 2009)",
          "Lead paint in homes in the United States estimated at US$ 11–53 billion of annual health care costs in children under 6years (Gould, 2009) Calculated lost lifetime earnings over US$ 165 billion among children estimated to have raised lead levels (Gould, 2009)",
          "Air pollution caused by road traffic costs the EU €25 billion per year (TU Dresden, 2012) Air pollution from industrial facilities costs the European Environment Agency €102–169 billion per year (EEA, 2011) Noise pollution from road traffic costs the EU €7 billion per year (TU Dresden, 2012) The cost of road traffic noise pollution in England is estimated to be £7–10 billion per year (United Kingdom)(DEFRA, 2013) Mercury emissions from coal burning in the United States reduce IQ, with a resultant US$ 1.3 billion loss in economic productivity(Trasande et al., 2005) Global costs from loss of productivity due to mercury pollution are expected to rise to US$ 29.4 billion by 2020 (Pacyna et al., 2008)"
        ]
      ],
      "notes": "a DALYs include 3% discounting and age weights.",
      "narratives": {
        "en": "For five risk factors (tobacco, harmful alcohol use, unhealthy diet, physical inactivity, environmental risks), the table gives DALYs lost in Europe and examples, with sources, of costs at the individual level, to health sectors and to governments or wider society.",
        "ar": "يعرض الجدول، لخمسة عوامل خطر (التبغ، والتعاطي الضار للكحول، والنظام الغذائي غير الصحي، والخمول البدني، والمخاطر البيئية)، سنوات العمر المصححة باحتساب مدد العجز المفقودة في أوروبا، وأمثلة موثقة المصادر على التكاليف على مستوى الأفراد والقطاعات الصحية والحكومات أو المجتمع الأوسع.",
        "zh": "该表针对五种风险因素（烟草、有害使用酒精、不健康饮食、缺乏身体活动、环境风险）列出欧洲损失的伤残调整生命年，以及个人层面、卫生部门和政府或更广泛社会所承担费用的示例及其来源。",
        "es": "Para cinco factores de riesgo (tabaco, consumo nocivo de alcohol, dieta malsana, inactividad física, riesgos ambientales), el cuadro presenta los AVAD perdidos en Europa y ejemplos, con sus fuentes, de los costos para las personas, para el sector de la salud y para los gobiernos o la sociedad en general.",
        "fr": "Pour cinq facteurs de risque (tabac, usage nocif de l’alcool, alimentation déséquilibrée, sédentarité, risques environnementaux), le tableau présente les DALY perdues en Europe et des exemples sourcés des coûts pour les individus, pour les secteurs de la santé et pour les pouvoirs publics ou la société.",
        "ru": "По пяти факторам риска (табак, вредное употребление алкоголя, нездоровое питание, недостаточная физическая активность, экологические риски) в таблице приведены потерянные в Европе DALY и примеры (с источниками) затрат на индивидуальном уровне, для сектора здравоохранения и для государства или общества в целом."
      },
      "csv": "tables/table-2b.csv"
    },
    {
      "label": "Table 3a",
      "caption": "Table 3a. “Best buy” interventions by risk factor",
      "pages": [
        19
      ],
      "columns": [
        {
          "titles": "Risk factor (DALYs lost, millions; % GBD)"
        },
        {
          "titles": "Intervention/action (core set of “best buys”)"
        },
        {
          "titles": "Avoidable burden (DALYs averted)"
        },
        {
          "titles": "Cost–effectiveness (Very: <GDP per person; Quite: <3 × GDP per person; Less: >3 × GDP per person)"
        },
        {
          "titles": "Implementation cost (Very low: <US$ 0.50; Quite low: <US$ 1; Higher: >US$ 1)"
        },
        {
          "titles": "Feasibility (health system constraints)"
        }
      ],
      "rows": [
        [
          "Tobacco use (>50; 3.7)",
          "Protect people from tobacco smoke Warn about the dangers of tobacco Enforce bans on tobacco advertising Raise taxes on tobacco",
          "Combined effect: 25–30 million DALYs averted (>50% tobacco burden)",
          "Very cost-effective",
          "Very low",
          "Highly feasible: strong framework (WHO Framework Convention on Tobacco Control (WHO, 2003))"
        ],
        [
          "",
          "Offer counselling to smokers",
          "",
          "Quite cost-effective",
          "Quite low",
          "Feasible (primary care)"
        ],
        [
          "Harmful use of alcohol (>50; 4.5)",
          "Restrict access to retailed alcohol Enforce bans on alcohol advertising Raise taxes on alcohol",
          "Combined effect: 5–10 million DALYs averted (10–20% alcohol burden)",
          "Very cost-effective",
          "Very low",
          "Highly feasible"
        ],
        [
          "",
          "Enforce drink–driving laws (breath-testing) Offer brief advice for hazardous drinking",
          "",
          "Quite cost-effective",
          "Quite low",
          "Intersectoral action; feasible (primary care)"
        ],
        [
          "Unhealthy diet (15–30; 1–2)",
          "Reduce salt intake Replace trans fat with polyunsaturated fat Promote public awareness about diet",
          "Effect of salt reduction: 5 million DALYs averted Other interventions: not yet assessed globally",
          "Very cost-effective",
          "Very low",
          "Highly feasible"
        ],
        [
          "",
          "Restrict marketing of food and beverages to children Replace saturated fat with unsaturated fat Manage food taxes and subsidies Offer counselling in primary care Provide health education in worksites Promote healthy eating in schools",
          "",
          "Very cost-effective? (more studies needed) Quite cost-effective Less cost-effective",
          "Very low Higher",
          "Highly feasible Feasible (primary care) Highly feasible"
        ],
        [
          "Physical inactivity (>30; 2.1)",
          "Promote physical activity (mass media)",
          "Not yet assessed globally",
          "Very cost-effective",
          "Very low",
          "Highly feasible"
        ],
        [
          "",
          "Promote physical activity (communities)",
          "",
          "Not assessed globally",
          "Not assessed globally",
          "Intersectoral action"
        ],
        [
          "",
          "Support active transport strategies Offer counselling in primary care Promote physical activity in worksites Promote physical activity in schools",
          "",
          "Quite cost-effective Less cost-effective",
          "Higher",
          "Feasible (primary care) Highly feasible"
        ],
        [
          "Infection",
          "Prevent liver cancer via hepatitis B vaccination",
          "Not yet assessed",
          "Very cost-effective",
          "Very low",
          "Feasible (primary care)"
        ]
      ],
      "notes": "Source: WHO (2011b). [In the unhealthy-diet second row and the physical-inactivity rows, the cost-effectiveness, cost and feasibility ratings are stacked against groups of interventions without a one-to-one alignment; they are kept together in single cells as printed.]",
      "narratives": {
        "en": "WHO “best buy” interventions for four NCD risk factors (tobacco use, harmful use of alcohol, unhealthy diet, physical inactivity) plus infection, with each risk factor’s DALYs lost and share of global burden, the avoidable burden, and ratings of cost-effectiveness, implementation cost and feasibility.",
        "ar": "تدخلات \"أفضل الخيارات\" التي حددتها المنظمة لأربعة عوامل خطر للأمراض غير السارية (تعاطي التبغ، والتعاطي الضار للكحول، والنظام الغذائي غير الصحي، والخمول البدني) إضافة إلى العدوى، مع سنوات العمر المصححة باحتساب مدد العجز المفقودة لكل عامل ونصيبه من العبء العالمي، والعبء الممكن تجنبه، وتقديرات المردودية وتكلفة التنفيذ وجدوى التطبيق.",
        "zh": "针对四种非传染性疾病风险因素（烟草使用、有害使用酒精、不健康饮食、缺乏身体活动）及感染的世卫组织“最合算措施”，列出各风险因素损失的伤残调整生命年及其占全球负担的比例、可避免负担，以及成本效益、实施成本和可行性评级。",
        "es": "Intervenciones «mejores inversiones» de la OMS para cuatro factores de riesgo de ENT (consumo de tabaco, consumo nocivo de alcohol, dieta malsana, inactividad física) más la infección, con los AVAD perdidos y la proporción de la carga mundial de cada factor, la carga evitable y la calificación de costoeficacia, costo de aplicación y viabilidad.",
        "fr": "Interventions « meilleurs choix » de l’OMS pour quatre facteurs de risque des MNT (tabagisme, usage nocif de l’alcool, alimentation déséquilibrée, sédentarité) ainsi que l’infection, avec les DALY perdues et la part de la charge mondiale de chaque facteur, la charge évitable et l’évaluation du rapport coût-efficacité, du coût de mise en œuvre et de la faisabilité.",
        "ru": "«Наиболее выгодные» меры ВОЗ в отношении четырех факторов риска НИЗ (употребление табака, вредное употребление алкоголя, нездоровое питание, недостаточная физическая активность), а также инфекции, с указанием потерянных DALY и доли глобального бремени для каждого фактора, предотвратимого бремени и оценок экономической эффективности, стоимости внедрения и осуществимости."
      },
      "csv": "tables/table-3a.csv"
    },
    {
      "label": "Table 3b",
      "caption": "Table 3b. “Best buy” interventions by health outcome",
      "pages": [
        20
      ],
      "columns": [
        {
          "titles": "Disease (DALYs lost, millions; % global burden)"
        },
        {
          "titles": "Intervention/action (core set of “best buys”)"
        },
        {
          "titles": "Avoidable burden (DALYs averted)"
        },
        {
          "titles": "Cost–effectiveness (Very: <GDP per person; Quite: <3 × GDP per person; Less: >3 × GDP per person)"
        },
        {
          "titles": "Implementation cost (Very low: <US$ 0.50; Quite low: <US$ 1; Higher: >US$ 1)"
        },
        {
          "titles": "Feasibility (health system constraints)"
        }
      ],
      "rows": [
        [
          "CVD and diabetes (170; 11.3)",
          "Counselling and multidrug therapy (including glycemic control for diabetes mellitus) for people (≥30 years) with 10-year risk of fatal or nonfatal cardiovascular events ≥30% Aspirin therapy for acute myocardial infarction",
          "60 million DALYs averted (35% CVD burden)",
          "Very cost-effective",
          "Quite low",
          "Feasible (primary care)"
        ],
        [
          "",
          "",
          "4 million DALYs averted (2% CVD burden)",
          "Very cost-effective",
          "Quite low",
          ""
        ],
        [
          "",
          "Counselling & multidrug therapy (including glycemic control for diabetes mellitus) for people (≥ 30 years) with a 10-year risk of fatal and nonfatal cardiovascular events ≥ 20%",
          "70 million DALYs averted (40% CVD burden)",
          "Quite cost-effective",
          "Higher",
          ""
        ],
        [
          "Cancer (78; 5.1)",
          "Cervical cancer – screening through visual inspection with acetic acid and treatment of pre-cancerous lesions to prevent cervical cancer",
          "5 million DALYs averted (6% cancer burden)",
          "Very cost-effective",
          "Very low",
          "Feasible (primary care)"
        ],
        [
          "",
          "Breast cancer – treatment of stage I",
          "3 million DALYs averted (4% cancer burden)",
          "Quite cost-effective",
          "Higher",
          "Not feasible in primary care (diagnosis and treatment requires secondary or tertiary care)"
        ],
        [
          "",
          "Breast cancer – early case-finding through mammographic screening (50–70 years) and treatment of all stages",
          "15 million DALYs averted (19% cancer burden)",
          "Quite cost-effective",
          "Higher",
          ""
        ],
        [
          "",
          "Colorectal cancer – screening at age 50 and treatment",
          "7 million DALYs averted (9% cancer burden)",
          "Quite cost-effective",
          "Quite low",
          ""
        ],
        [
          "",
          "Oral cancer – early detection and treatment",
          "Not assessed globally",
          "Not assessed globally",
          "Not assessed",
          ""
        ],
        [
          "Respiratory disease (60; 3.9)",
          "Treatment of persistent asthma with inhaled corticosteroids & beta-2 agonists",
          "Not assessed globally (expected to be small)",
          "Quite cost-effective",
          "Very low",
          "Feasible (primary care)"
        ]
      ],
      "notes": "Source: WHO (2011b).",
      "narratives": {
        "en": "WHO “best buy” interventions for three disease groups (CVD and diabetes, cancer, respiratory disease), with each group’s DALYs lost and share of global burden, the avoidable burden per intervention, and ratings of cost-effectiveness, implementation cost and feasibility.",
        "ar": "تدخلات \"أفضل الخيارات\" التي حددتها المنظمة لثلاث مجموعات من الأمراض (أمراض القلب والأوعية الدموية والسكري، والسرطان، والأمراض التنفسية)، مع سنوات العمر المصححة باحتساب مدد العجز المفقودة لكل مجموعة ونصيبها من العبء العالمي، والعبء الممكن تجنبه لكل تدخل، وتقديرات المردودية وتكلفة التنفيذ وجدوى التطبيق.",
        "zh": "针对三类疾病（心血管疾病和糖尿病、癌症、呼吸系统疾病）的世卫组织“最合算措施”，列出各类疾病损失的伤残调整生命年及其占全球负担的比例、每项干预措施可避免的负担，以及成本效益、实施成本和可行性评级。",
        "es": "Intervenciones «mejores inversiones» de la OMS para tres grupos de enfermedades (ECV y diabetes, cáncer, enfermedades respiratorias), con los AVAD perdidos y la proporción de la carga mundial de cada grupo, la carga evitable por intervención y la calificación de costoeficacia, costo de aplicación y viabilidad.",
        "fr": "Interventions « meilleurs choix » de l’OMS pour trois groupes de maladies (MCV et diabète, cancer, maladies respiratoires), avec les DALY perdues et la part de la charge mondiale de chaque groupe, la charge évitable par intervention et l’évaluation du rapport coût-efficacité, du coût de mise en œuvre et de la faisabilité.",
        "ru": "«Наиболее выгодные» меры ВОЗ для трех групп болезней (ССЗ и диабет, рак, болезни органов дыхания) с указанием потерянных DALY и доли глобального бремени по каждой группе, предотвратимого бремени по каждой мере и оценок экономической эффективности, стоимости внедрения и осуществимости."
      },
      "csv": "tables/table-3b.csv"
    },
    {
      "label": "Table 4a",
      "caption": "Table 4a. Cost-effective interventions to build resilience: factors affecting health behaviours and outcomes",
      "pages": [
        22,
        23
      ],
      "columns": [
        {
          "titles": "Focus"
        },
        {
          "titles": "Return on investment"
        },
        {
          "titles": "Cost saving"
        }
      ],
      "rows": [
        [
          "Violence and abuse",
          "Violence Against Women Act of 1994 (United States) (Clark et al., 2002) • Empirical evaluation • Timescale: 1 year At the government level • Cost: US$ 1.6 billion for programmes over 5 years • Saving: US$ 14.8 billion in net averted social costs At the individual level • Cost: US$ 15.50 per woman • Saving: US$ 159 per woman in averted costs of criminal victimization School-based interventions to reduce bullying (United Kingdom) (Knapp et al., 2011) • Modelling study • Timescale: no finite timescale • Cost: £15.50 per pupil per year • Saving: £1080 per pupil Perry preschool program in Ypsilanti, Michigan (United States) (Anderson et al., 2003) • Modelling study • Timescale: lifetime estimate • Net savings: US$ 108 516 for males and US$ 110 333 for females Cost–benefit analysis of multisystemic therapy (MST) with serious and violent juvenile offenders (United States) (Klietz et al., 2010) • Timescale: 13.7 years • Cost: US$ 10 882 per MST participant • Return on investment: US$ 9.51–23.59 for every dollar spent on MST (savings to taxpayer and crime victims) Identification and Referral to Improve Safety (IRIS), a domestic violence training and support programme for primary care (United Kingdom) (Devine et al., 2012) • Modelling study • Timescale: within 1 year • Cost: £136 per woman registered in the primary care practice • Savings: £37 per woman registered in the primary care practice (£178 saved to a cost of £136) (societal perspective)",
          "Cost–effectiveness of a programme to detect and provide better care for female victims of intimate partner violence (United Kingdom) (Norman et al., 2010) • Modelling study • Timescale: 10 years • Cost: £5210 per year • Incremental cost–effectiveness ratio (ICER): £742 per quality-adjusted life-year (QALY) (societal perspective)"
        ],
        [
          "Mental health",
          "Early identification of postnatal depression with intervention (health visitor) (United Kingdom) (Petrou et al., 2006) • Empirical study • Timescale: 18 months • Cost: preventive intervention group cost £119 more than standard treatment • Net savings: £383 per mother–infant pair per month (societal) Antisocial behaviour family support projects (United Kingdom) (Nixon et al., 2006) • Empirical study • Timescale: 2 years • Cost: £8000–15000 per family per year • Savings: £17–44 for every £1 spent Reducing conduct problems through school-based social and emotional learning (United Kingdom) (Knapp et al., 2011) • Cost: £132 per pupil per year • Savings of £39 to health sector in first year, rising to £751 by fifth year • Net societal savings of £6369 for whole of society by fifth year (mostly through reduced crime) Intervention for prevention of childhood conduct disorder for a one-year cohort (United Kingdom) (Friedli& Parsonage, 2007) • Empirical study • Timescale: based on projected lifetime savings • Cost: £210 million or £6000 per individual programme • Savings: £5.2 billion or £150 000 per case Psychosocial group therapy for older people identified as lonely (Finland) (Pitkala et al., 2009) • Empirical study • Timescale: 2 years • Cost: €881 per person • Savings: Mean net reduction in health care costs: €943 per person per year One-day training programme for police officers that improves interactions with mentally ill individuals (Canada) (Krameddine et al., 2013) • Experimental study • Timescale: 6 months • Cost: US$ 120 per officer • Savings: more than US$ 80 000 in the following 6 months",
          "Cost–effectiveness analysis of parenting programmes for parents of children at risk of developing conduct disorder (United Kingdom) (Bywater et al., 2009) • Costs for children with conduct problems reduced from £5350 to £1034 after 18 months following parent training intervention Population cost–effectiveness of interventions designed to prevent childhood depression (ages 11–17) (Australia) (Mihalopoulos et al., 2012) • Modelling study • ICER: US$ 5400 per DALY (health sector perspective) Cost–effectiveness of a stepped care intervention to prevent depression and anxiety in late life (Netherlands) (Van’t Veer-Tazelaar et al., 2010) • Experimental study • Timescale: 1 year • Cost: €563 per recipient • € 4367 per disorder-free year gained Mental health promotion and the prevention of depression in older age: regular participation in exercise classes by older people in England (United Kingdom) (Munro et al., 2004) • Timescale: within 2 years • Cost-effective in England: €17 172 per QALY (2004 prices) (health system perspective) Befriending of older adults (United Kingdom) (Knapp et al., 2011) • Timescale: in the first year for the NHS • Cost £85 per older person • Approximate savings of £40 per £85 invested"
        ]
      ],
      "notes": "Each cell lists several studies: a title in bold followed by country, reference and bulleted findings; they are joined here in reading order. Continued on p23 (\"contd.\").",
      "narratives": {
        "en": "Examples of resilience-building interventions on violence and abuse and on mental health, each with country, source, study type, timescale and costs, sorted by whether they showed a return on investment or were cost saving/cost-effective.",
        "ar": "أمثلة على تدخلات بناء القدرة على الصمود في مجالي العنف والإساءة والصحة النفسية، مع البلد والمصدر ونوع الدراسة والإطار الزمني والتكاليف لكل منها، مصنفة بحسب ما إذا كانت قد حققت عائداً على الاستثمار أو كانت موفرة للتكاليف/عالية المردودية.",
        "zh": "针对暴力与虐待以及精神卫生的增强复原力干预措施示例，每项均列出国家、来源、研究类型、时间范围和费用，并按显示出投资回报或节约成本/具有成本效益加以分类。",
        "es": "Ejemplos de intervenciones para fortalecer la resiliencia en materia de violencia y abuso y de salud mental, cada una con país, fuente, tipo de estudio, plazo y costos, clasificadas según hayan mostrado retorno de la inversión o ahorro de costos/costoeficacia.",
        "fr": "Exemples d’interventions visant à renforcer la résilience dans les domaines de la violence et de la maltraitance et de la santé mentale, chacune avec pays, source, type d’étude, horizon temporel et coûts, classées selon qu’elles ont montré un retour sur investissement ou des économies/un bon rapport coût-efficacité.",
        "ru": "Примеры мер по укреплению жизнестойкости в сферах насилия и жестокого обращения и психического здоровья с указанием страны, источника, типа исследования, временных рамок и затрат, распределенные по признаку окупаемости инвестиций или экономии затрат/экономической эффективности."
      },
      "csv": "tables/table-4a.csv"
    },
    {
      "label": "Table 4b",
      "caption": "Table 4b. Cost-effective interventions to address social determinants of health",
      "pages": [
        24
      ],
      "columns": [
        {
          "titles": "Determinant"
        },
        {
          "titles": "Return on investment"
        },
        {
          "titles": "Cost saving"
        }
      ],
      "rows": [
        [
          "Housing",
          "Affordable warm housing: insulation and heating (United Kingdom) (CIEH, 2008) • Investment of £251 million to reduce domestic impacts of excess cold • Savings of £859 million (assuming full coverage) will result in a £608 million return of savings to NHS (England) • Return on investment within 0.3 years Supported housing for families with complex emotional needs and chaotic lives (United Kingdom) (Department of Health, 2009) • Empirical study(pilot project in 1999) • Timescale: unavailable • Savings: £12 000 per client for local authorities Preventing bath water scalds: a cost–effectiveness analysis of introducing bath thermostatic mixer valves in social housing (United Kingdom) (Phillips et al., 2011) • Costs: treating bath water scald £25 226–71 902 • Net saving: £1887–75 520 • Return on investment: £1.41 saved for every £1 spent",
          "Enhancing ventilation in homes of children with asthma (United Kingdom) (Edwards et al., 2011) • Cost–effectiveness study alongside randomized control trial • Timescale: 12 months • Cost: £1718 per child given tailored package of housing interventions (ventilation and heating) • ICER: £234 per point improvement on asthma scale (£165 for children with severe asthma) Falls prevention leaflets (United Kingdom) (Irvine et al., 2010) • Timescale: 12 months • Cost: £349 per person • ICER: £3320 per fall averted"
        ],
        [
          "Debt",
          "Debt advice services (United Kingdom) (Knapp et al., 2011) • Modelling study • Timescale: 2–5 years • Pay-off: £2.92 per £1 expenditure",
          "–"
        ],
        [
          "Employment",
          "Individual active treatment combined with group exercise for acute and subacute low back pain (United Kingdom) (Wright et al., 2005) • Savings: £250–578 per patient • Timescale: 1–2 weeks Coordinated and tailored work rehabilitation undertaken with workers on sick leave due to musculoskeletal disorders (Denmark) (Bultmann et al., 2009) • Economic evaluation based on a randomized controlled trial • Timescale: 6–12 months • Cost: US$ 2200 per person • Savings: US$ 1366 per person at 6 months; US$ 10 666 per person at 12 months Workplace screening for depression and anxiety disorder (United Kingdom) (Knapp et al., 2011) • Modelling study • Timescale: 1–2 years • Cost: £20 600 in first year (per 500 employees) • Savings: £19 700 (500 employees) in first year and £63 500 by second year Mental health promotion and prevention of depression in the workplace: early diagnosis and intervention for employees with depressive symptoms (United States) (Wang et al., 2007) • Empirical study • Timescale: 1 year • Cost: US$ 100–400 per person per year • Savings: US$ 1800 per employee per year Promoting well-being in the workplace (United Kingdom) (Knapp et al., 2011) • Modelling study • Timescale: 1 year • Cost: £40 000 • Savings: £340 000 within 1 year",
          "Seasonal influenza vaccination of healthy working-age adults (United States) (Gatwood et al, 2012) • Review of economic evaluations • Costs: US$ 85.92 per person • Net savings: US$ 68.96 per person • Cost–effectiveness ratio (2 studies): US$ 26 565–50 512 per QALY (societal perspective)"
        ]
      ],
      "notes": "Each cell lists several studies: a title in bold followed by country, reference and bulleted findings; they are joined here in reading order.",
      "narratives": {
        "en": "Examples of interventions on social determinants of health (housing, debt, employment), each with country, source, study type, timescale and costs, sorted by whether they showed a return on investment or were cost saving/cost-effective.",
        "ar": "أمثلة على تدخلات تعالج المحددات الاجتماعية للصحة (السكن، والديون، والعمل)، مع البلد والمصدر ونوع الدراسة والإطار الزمني والتكاليف لكل منها، مصنفة بحسب ما إذا كانت قد حققت عائداً على الاستثمار أو كانت موفرة للتكاليف/عالية المردودية.",
        "zh": "针对健康问题社会决定因素（住房、债务、就业）的干预措施示例，每项均列出国家、来源、研究类型、时间范围和费用，并按显示出投资回报或节约成本/具有成本效益加以分类。",
        "es": "Ejemplos de intervenciones sobre los determinantes sociales de la salud (vivienda, deudas, empleo), cada una con país, fuente, tipo de estudio, plazo y costos, clasificadas según hayan mostrado retorno de la inversión o ahorro de costos/costoeficacia.",
        "fr": "Exemples d’interventions portant sur les déterminants sociaux de la santé (logement, endettement, emploi), chacune avec pays, source, type d’étude, horizon temporel et coûts, classées selon qu’elles ont montré un retour sur investissement ou des économies/un bon rapport coût-efficacité.",
        "ru": "Примеры мер в отношении социальных детерминант здоровья (жилье, задолженность, занятость) с указанием страны, источника, типа исследования, временных рамок и затрат, распределенные по признаку окупаемости инвестиций или экономии затрат/экономической эффективности."
      },
      "csv": "tables/table-4b.csv"
    },
    {
      "label": "Table 4c",
      "caption": "Table 4c. Cost-effective interventions to address environmental determinants of health",
      "pages": [
        25,
        26
      ],
      "columns": [
        {
          "titles": "Determinant"
        },
        {
          "titles": "Return on investment"
        },
        {
          "titles": "Cost saving"
        }
      ],
      "rows": [
        [
          "Road traffic injuries",
          "Nationwide speed limit reduction (United States) (Shafi et al., 2008) • Cost–benefit analysis • Timescale: 1 year • Savings: US$ 13 billion annually (including a US$ 2 billion reduction in trauma care costs) Seat-belt use (United States) (Shafi et al., 2008) • Timescale: 1 year • Savings: US$ 50 billion annually Airbag use (United States) (Shafi et al., 2008) • Timescale: 1 year • Savings: US$ 1.94 billion annually Photo radar speed enforcement programme on an inner city motorway (Spain) (Perez et al., 2007) • Empirical study • Timescale: 2 years • Cost: €14.5 million • Net savings: €6.8 million over 2 years Economic cost savings associated with state motorcycle helmet laws (United Sates) (CDC, 2012) • Timescale: 2 years • Savings: US$ 725 per registered motorcycle (societal perspective) Alcohol-impaired driving: “The Australian Campaign” (Australia) (Elder et al., 2004) • Modelling study • Timescale: 23 months • Costs: AU$ 403 174 per month • Savings: AU$ 8 324 532 per month, including AU$ 3 214 096 in averted medical costs Safety camera enforced speed limits (United Kingdom) (Gains et al., 2005) • Empirical study • Timescale: 4 years • Costs: £96 million per year • Savings: £258 million per year",
          "Injury awareness education programme on outcomes of juvenile justice offenders in western Australia (Australia) (Ho et al., 2012) • Economic analysis • Timescale: 5 years • Cost of programme: US$ 33 735 • Annual savings: US$ 3765 (from serious injury) • Cost–effectiveness: • cost per offence prevented: US$ 3124; • cost per serious injury avoided: US$ 42 169; cost per discounted life-year gained: US$ 17 910"
        ],
        [
          "Green space",
          "The US study for Philadelphia city parks (United States) (Trust for Public Land, 2008) • Empirical study • Timescale: within 5 years • Savings: US$ 69.4 million per year through avoided health care costs Conservation volunteering projects (United Kingdom) (Greenspace Scotland, 2009) • Empirical study • Timescale: over 5 years • Return on investment: £7.35 for every £1 invested",
          "–"
        ],
        [
          "Climate",
          "Heat warning systems (Europe) (Toloo et al., 2013) • Systematic review • Timescale: 4 years • Cost: US$ 210 000 • Savings: US$ 468 million",
          "–"
        ],
        [
          "Active transport",
          "Switching from car to active transport (United Kingdom) (Davis, 2011) • Modelling study • Timescale: 1 year • Benefits of moving from car to walking: £1220 per year • Benefits of moving from car to cycling: £1121 per year Introducing pedestrian crossings and other pedestrian facilities for 579 schemes (United Kingdom) (Gorell&Tootill, 2001) • Timescale: 1 year • Net first year rate of return – 246% Effect of increasing active travel in urban England and Wales on costs to the NHS (United Kingdom) (Jarrett et al., 2012) • Timescale: 20 years • Savings: £17 billion for the NHS (reduction in the prevalence of type 2 diabetes, dementia, ischaemic heart disease, cerebrovascular disease and cancer)",
          "Counselling programmes to promote physical activity and a community- based walking scheme (United Kingdom) (Windle et al., 2008) • Timescale 6 months • Cost: £9.50–220 per participant (community-based) • QALY gains: from 3.0 per 1000 individuals over 6 months (physical activity counselling intervention) to 28.3 per 1000 individuals over 6 months (community-based walking programme)"
        ],
        [
          "Environmental hazards",
          "Reducing childhood exposure to mercury through mercury and air toxics standards (MATS) (United States) (EPA, 2011) • Empirical study • Timescale: 10 years • Savings: > US$ 37 billion per year in health benefits Window replacement and residential lead paint hazard control (United States) (Dixon et al., 2012) • Timescale: 12 years • Net savings: US$ 1700–2000 per housing unit Removal of lead from domestic paint and plumbing in at-risk neighbourhoods (France) (Pichery et al., 2011) • Modelling study • Timescale: projected life-year • Cost: €3600–9200 per home • Savings: €8800–51 400 reduction in cost of illness per de-leaded home",
          "–"
        ]
      ],
      "notes": "Each cell lists several studies: a title in bold followed by country, reference and bulleted findings; they are joined here in reading order. Continued on p26 (\"contd.\").",
      "narratives": {
        "en": "Examples of interventions on environmental determinants of health (road traffic injuries, green space, climate, active transport, environmental hazards), each with country, source, study type, timescale and costs, sorted by whether they showed a return on investment or were cost saving/cost-effective.",
        "ar": "أمثلة على تدخلات تعالج المحددات البيئية للصحة (إصابات حوادث المرور، والمساحات الخضراء، والمناخ، والنقل النشط، والمخاطر البيئية)، مع البلد والمصدر ونوع الدراسة والإطار الزمني والتكاليف لكل منها، مصنفة بحسب ما إذا كانت قد حققت عائداً على الاستثمار أو كانت موفرة للتكاليف/عالية المردودية.",
        "zh": "针对健康问题环境决定因素（道路交通伤害、绿地、气候、主动出行、环境危害）的干预措施示例，每项均列出国家、来源、研究类型、时间范围和费用，并按显示出投资回报或节约成本/具有成本效益加以分类。",
        "es": "Ejemplos de intervenciones sobre los determinantes ambientales de la salud (traumatismos por accidentes de tránsito, espacios verdes, clima, transporte activo, peligros ambientales), cada una con país, fuente, tipo de estudio, plazo y costos, clasificadas según hayan mostrado retorno de la inversión o ahorro de costos/costoeficacia.",
        "fr": "Exemples d’interventions portant sur les déterminants environnementaux de la santé (traumatismes dus aux accidents de la route, espaces verts, climat, transport actif, dangers environnementaux), chacune avec pays, source, type d’étude, horizon temporel et coûts, classées selon qu’elles ont montré un retour sur investissement ou des économies/un bon rapport coût-efficacité.",
        "ru": "Примеры мер в отношении экологических детерминант здоровья (дорожно-транспортный травматизм, зеленые зоны, климат, активный транспорт, экологические опасности) с указанием страны, источника, типа исследования, временных рамок и затрат, распределенные по признаку окупаемости инвестиций или экономии затрат/экономической эффективности."
      },
      "csv": "tables/table-4c.csv"
    },
    {
      "label": "Table 4d",
      "caption": "Table 4d. Cost-effective interventions for vaccination and screening",
      "pages": [
        27
      ],
      "columns": [
        {
          "titles": "Intervention"
        },
        {
          "titles": "Return on investment"
        },
        {
          "titles": "Cost saving"
        }
      ],
      "rows": [
        [
          "Vaccination",
          "Pneumococcal vaccination in Spain (children under 2) (Spain) (Morano et al., 2011) • Timescale: 1 year • Cost: €38.36 per dose + €4.88 administration per person • Savings: €22 million Human norovirus vaccine (United States) (Bartsch et al., 2012) • Timescale: 2 years • Cost of vaccine: US$ 400 million–1 billion • Savings: US$ 2.1 billion Rotavirus vaccine and health care utilization for diarrhoea in children (United States) (Cortes et al., 2011) • Timescale: 2 years • Savings: US$ 278 million in reduced treatment costs Measles, mumps and rubella (MMR) vaccination (United Kingdom) (WHO, 2013b) • Modelling study • Timescale: 10 years • Costs: £0.17–0.97 per person • Savings: £240 730–544 490 over 10 years in reduced treatment costs Flu vaccine (United Kingdom) (Scuffham& West, 2002; Burls et al., 2006) • Modelling study • Timescale: projected lifetime • Return on investment: £1.35 for every £1 spent on targeted flu vaccination • Savings rise to £12 per vaccination when health care workers are vaccinated",
          "Hepatitis B vaccination (United States) (Margolis et al., 1995) • Modelling study • Timescale: projected lifetime • US$ 164 per life-year saved for perinatal immunization (societal perspective) Rotavirus vaccination (Armenia) (Jit et al., 2011) • Timescale: 1 year • Cost: US$ 220 000 in 2012; US$ 830 000 in 2016; US$ 260 000 in 2025 • Cost effectiveness: US$ 650 per DALY (health sector perspective); US$ 820 per DALY (societal perspective) Implementation of bivalent Human papillomavirus vaccination in young women in addition to cervical cancer screening for women over 40 years (Netherlands) (Coupe et al., 2009) • Timescale: 10 years • Cost–effectiveness: €19 500 per QALY Human papillomavirusvaccination programmes (Austria) (Zechmeister et al., 2009) • ICER for girls: €64,000 per life-year gained and €50,000 per life-year gained (payer’s and societal perspectives, respectively) Human papillomavirus vaccination (Iceland) (Oddsson et al., 2009) • Modelling study • ICER: €18 500 per QALY saved"
        ],
        [
          "Screening (Note: cancer screening not included here as covered in Table 3b)",
          "–",
          "Standard vascular disease health check (France) (Schuetz et al., 2013) • Timescale: 30 years • Cost–effectiveness: offering health checks to all: €14 903 per QALY; offering health checks only to higher-risk(obese) individuals: €10 200 or less per QALY Screening for diabetes and impaired glucose tolerance (United Kingdom) (Gillies et al., 2008) • Modelling study • Timescale: 50 years • Cost–effectiveness: £6242 per QALY"
        ]
      ],
      "notes": "Each cell lists several studies: a title in bold followed by country, reference and bulleted findings; they are joined here in reading order.",
      "narratives": {
        "en": "Examples of vaccination and screening interventions, each with country, source, study type, timescale and costs or cost-effectiveness ratios, sorted by whether they showed a return on investment or were cost saving/cost-effective; cancer screening is excluded as it is covered in Table 3b.",
        "ar": "أمثلة على تدخلات التطعيم والفحص، مع البلد والمصدر ونوع الدراسة والإطار الزمني والتكاليف أو نسب المردودية لكل منها، مصنفة بحسب ما إذا كانت قد حققت عائداً على الاستثمار أو كانت موفرة للتكاليف/عالية المردودية؛ ويُستثنى فحص السرطان لأنه مشمول في الجدول 3ب.",
        "zh": "疫苗接种和筛查干预措施示例，每项均列出国家、来源、研究类型、时间范围和费用或成本效益比，并按显示出投资回报或节约成本/具有成本效益加以分类；癌症筛查已在表3b中涵盖，故未列入。",
        "es": "Ejemplos de intervenciones de vacunación y cribado, cada una con país, fuente, tipo de estudio, plazo y costos o razones de costoeficacia, clasificadas según hayan mostrado retorno de la inversión o ahorro de costos/costoeficacia; se excluye el cribado del cáncer, tratado en el cuadro 3b.",
        "fr": "Exemples d’interventions de vaccination et de dépistage, chacune avec pays, source, type d’étude, horizon temporel et coûts ou ratios coût-efficacité, classées selon qu’elles ont montré un retour sur investissement ou des économies/un bon rapport coût-efficacité ; le dépistage du cancer est exclu car traité au tableau 3b.",
        "ru": "Примеры мер по вакцинации и скринингу с указанием страны, источника, типа исследования, временных рамок и затрат или коэффициентов эффективности затрат, распределенные по признаку окупаемости инвестиций или экономии затрат/экономической эффективности; скрининг на рак не включен, так как рассмотрен в таблице 3b."
      },
      "csv": "tables/table-4d.csv"
    }
  ],
  "coverage": [
    {
      "kind": "contents",
      "state": "found",
      "count": 11,
      "note": "outline"
    },
    {
      "kind": "sections",
      "state": "found",
      "count": 11,
      "note": "one level"
    },
    {
      "kind": "figures",
      "state": "found",
      "count": 8
    },
    {
      "kind": "tables",
      "state": "found",
      "count": 9
    },
    {
      "kind": "references",
      "state": "not-extracted",
      "note": "a references section is in the text (p29); its entries are not extracted"
    },
    {
      "kind": "glossary",
      "state": "not-extracted",
      "note": "a glossary section is in the text (p29); its entries are not extracted"
    },
    {
      "kind": "footnotes",
      "state": "not-extracted"
    },
    {
      "kind": "summaries",
      "state": "found",
      "count": 11,
      "note": "11 of 11 sections"
    }
  ],
  "links": {
    "repo": "litlfred/who-iris",
    "branch": "main",
    "dir": "library/10665-351406"
  }
}
